Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening

Launched by H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE · Dec 17, 2024

Keywords

ClinConnect Summary

The MATCHES trial is designed to help people aged 45 to 75 who receive care at certain clinics learn more about and get screened for two important health issues: colorectal cancer (CRC) and hepatitis C virus (HCV). The goal is to encourage patients who may not have had the recommended screenings for these conditions to participate in this study. If you haven't had a colonoscopy in the last 10 years or a blood test for hepatitis C, you may be eligible to join.

To participate, you should be generally healthy and not have any symptoms of these diseases. You'll be asked to read and complete some surveys and may even take part in a remote interview about your experience. This study aims to make sure that patients are informed about their health and have access to important screenings that can help catch these conditions early. If you think you might qualify, this could be a great opportunity to take charge of your health!

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Participants must be receiving care at one of the participating FQHC clinics.
• • Participants must be 45-75 years of age.
• • Participants must not be up to date with Colorectal Cancer (CRC) screening recommendations such as no colonoscopy in the past 10 years, occult blood test in the past 12 months.
• • Participants must never have had Hepatitis C Virus (HCV) antibody screening.
• • Participants must be able to read, write, and understand English or Spanish.
• • Participants must have no personal history of CRC or current presumptive CRC symptoms such as unresolved rectal bleeding or abdominal pain/bloating.
• • Participants must be at average risk for CRC (no hereditary CRC syndromes such as lower gastrointestinal (GI) bleeding, persistent diarrhea, bloating, or lower GI pain, no strong family history of CRC).
• • Participants must be asymptomatic for HCV.
• • Participants receiving intervention materials must be able and willing to complete surveys and receive the patient level intervention.
• • Participants completing qualitative interviews must be willing to complete a remote interview via phone or teleconference software such as ZOOM.
• • Participants completing qualitative interviews must be willing to be audio recorded.
• • Participants recruited for qualitative interviews only (did not receive MATCHES intervention materials) must have a clinic visit within prior two months.
• • All Participants must be able to provide informed consent.
• Exclusion Criteria:
• • Participants that do not meet all Inclusion Eligibility requirements will be excluded.